Hongyuan Zhou
Tianjin Key Laboratory Of Digestive Cancer, Huan Hu Xi Road
Tianjin, 300060, China
Tianjin, 300060, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Long-term follow-up of third generation anti-CD30 CAR T-cell therapy in relapsed/refractory CD30+ lymphomas: a single-arm, multicentre, phase 1-2 trial.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: April 06, 2026
Laparoscopic vs. open liver resection for malignancies involving segment 7: short-term outcomes and learning curve analysis using propensity score matching.
Journal: Surgical endoscopy
Published: July 11, 2025
Inhibition of nuclear receptor coactivator 5 overcomes acquired lenvatinib resistance driven by protein kinase B-mammalian target of rapamycin signaling in hepatocellular carcinoma.
Journal: Anti-cancer drugs
Published: May 14, 2025
A LASSO Cox Regression Predictive Model for Patients Undergoing Surgery for Pancreatic Body and Tail Adenocarcinoma Patients: Comparative Long-Term Survival Analysis of Radical Antegrade Modular Pancreatosplenectomy (RAMPS) and Standard Retrograde Pancreatosplenectomy (SPRS).
Journal: Annals of surgical oncology
Published: March 19, 2024
A prognostic signature of cuproptosis and TCA-related genes for hepatocellular carcinoma.
Journal: Frontiers in oncology
Published: September 09, 2022
Elevated serum CA19-9 indicates severe liver inflammation and worse survival after curative resection in hepatitis B-related hepatocellular carcinoma.
Journal: Bioscience trends
Published: December 09, 2021
Conversion therapy and maintenance therapy for primary hepatocellular carcinoma.
Journal: Bioscience trends
Published: May 27, 2021
Systemic treatment of advanced or recurrent biliary tract cancer.
Journal: Bioscience trends
Published: August 25, 2020
Next-generation sequencing-guided molecular-targeted therapy and immunotherapy for biliary tract cancers.
Journal: Cancer immunology, immunotherapy : CII
Published: July 08, 2020
MicroRNA-361 suppresses the biological processes of hepatic stellate cells in HBV-relative hepatic fibrosis by NF-kappaB p65.
Journal: Cells & development
Published: June 22, 2020
Last Updated: 09/26/2026